Hosted on MSN50m
Study shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetesKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback